Objective: To compare the effects of different rest intervals (RI) between sets of isokinetic contractions on muscle performance in older adults. Methods: Twenty older participants (66.9±3.9 years; 76.1±13.4kg; 169±5.2cm) underwent three sessions of unilateral isokinetic training for the knee extensor muscles, with different RI (1 minute, 2 minutes and 3 minutes) at an angular velocity of 60°•s -1 .Each session consisted of three sets of 10 repetitions, during which the peak torque (PT), total work (TW) and fatigue index (FI) were evaluated. Factorial ANOVA for repeated measurements, with Bonferroni post-hoc analysis, was used to identify possible differences between the RI. The statistical significance level was set at p<0.05. Results: No differences in muscle performance during the first sets were observed between the different RI (p>0.05). Although muscle performance was lower during the third sets with all RI, the greatest decreases in PT, TW and FI occurred with the 1 minute RI (p<0.05). Conclusion: The results showed that the RI variable has an important influence on isokinetic muscle performance in older adults, particularly from the third sets onwards, which suggests that RI should be increased as successive sets are performed within the same exercise session.Article registered in the Clinical Trials under the number NDT00673998.Key words: resistance exercise; muscle strength; isokinetic contraction; older adults.
ResumoObjetivo: Comparar os efeitos de diferentes intervalos de recuperação (IR) entre séries de contração isocinética no desempenho muscular em idosos. Métodos: Vinte idosos voluntários (66,9±3,9 anos, 76,1±13,4kg, 169±5,2cm) foram submetidos a três sessões de exercício resistido isocinético unilateral da musculatura extensora do joelho com diferentes IR (1 minuto, 2 minutos, e 3 minutos) na velocidade de 60°•s Palavras-chave: exercício resistido; força muscular; contração isocinética; idosos.
The present study aimed to determine the ideal requirement of digestible methionine + cystine to molted laying hens. The experimental period lasted 105 days, divided into five periods of 21 days. 144 Hisex White laying hens with 84 weeks-of-age were used. The experimental design was completely randomized with treatments constituted for six levels of digestible methionine + cystine (0.45, 0.50, 0.55, 0.60, 0.65, and 0.70%) in the diets, with four replicates of six birds each. Data collected were evaluated by polynomial regression at 5%. There was a significant effect (p<0.05) of digestible methionine + cystine on feed intake, energy intake, protein intake, egg production, and egg mass. Internal egg quality presented positive linear effect (p<0.05) on albumen height and yolk color. External egg quality was affected (p<0.05) in eggshell %, eggshell thickness and eggshell resistance, where the level of 0.60% of digestible methionine + cystine in the diets provided eggshells with better quality (higher percentage, thicker and breaking resistance). Differences (p<0.05) were also observed in glucose and triglycerides concentration, with 0.60% of digestible methionine + cystine in the diets presenting better equilibrium. Results of the present study suggested that higher levels of digestible methionine + cystine improved the performance and internal egg quality of molted laying hens. The level of 0.60% of digestible methionine + cystine provided better eggshell and equilibrium on blood biochemistry.
Background: To evaluate the effect of alopurinol after lung ischemia-reperfusion (IR) injury under ventilation with different inspired oxygen concentrations (0.21 and 1.00 pO2) on physiological responses and tissue damage and antioxidants present in lung parenchyma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.